Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer.
Kiebish MA, Cullen J, Mishra P, Ali A, Milliman E, Rodrigues LO, Chen EY, Tolstikov V, Zhang L, Panagopoulos K, Shah P, Chen Y, Petrovics G, Rosner IL, Sesterhenn IA, McLeod DG, Granger E, Sarangarajan R, Akmaev V, Srinivasan A, Srivastava S, Narain NR, Dobi A. Kiebish MA, et al. Among authors: tolstikov v. J Transl Med. 2020 Jan 7;18(1):10. doi: 10.1186/s12967-019-02185-y. J Transl Med. 2020. PMID: 31910880 Free PMC article.
Metabolomic effects of androgen deprivation therapy treatment for prostate cancer.
Chi JT, Lin PH, Tolstikov V, Oyekunle T, Chen EY, Bussberg V, Greenwood B, Sarangarajan R, Narain NR, Kiebish MA, Freedland SJ. Chi JT, et al. Among authors: tolstikov v. Cancer Med. 2020 Jun;9(11):3691-3702. doi: 10.1002/cam4.3016. Epub 2020 Mar 31. Cancer Med. 2020. PMID: 32232974 Free PMC article. Clinical Trial.
Impact of hemolysis on multi-OMIC pancreatic biomarker discovery to derisk biomarker development in precision medicine studies.
Searfoss R, Shah P, Ofori-Mensa K, Bussberg V, Tolstikov V, Greenwood B, Li H, Richardson K, Miller GM, DeCicco C, Granger E, Rodrigues LO, Grund EM, Moser AJ, Sarangarajan R, Narain NR, Kiebish MA. Searfoss R, et al. Among authors: tolstikov v. Sci Rep. 2022 Jan 24;12(1):1186. doi: 10.1038/s41598-022-05152-8. Sci Rep. 2022. PMID: 35075163 Free PMC article.
CRISPR-engineered human brown-like adipocytes prevent diet-induced obesity and ameliorate metabolic syndrome in mice.
Wang CH, Lundh M, Fu A, Kriszt R, Huang TL, Lynes MD, Leiria LO, Shamsi F, Darcy J, Greenwood BP, Narain NR, Tolstikov V, Smith KL, Emanuelli B, Chang YT, Hagen S, Danial NN, Kiebish MA, Tseng YH. Wang CH, et al. Among authors: tolstikov v. Sci Transl Med. 2020 Aug 26;12(558):eaaz8664. doi: 10.1126/scitranslmed.aaz8664. Sci Transl Med. 2020. PMID: 32848096 Free PMC article.
66 results